Rocket Lab Announces Second Quarter 2026 Financial Results: Posts Record Revenue and Record Backlog, Guides To Another Record Revenue Quarter in Q3 2026
Rhea-AI Summary
Rocket Lab (Nasdaq: RKLB) reported record Q2 2026 revenue of $234.1 million, up 62% year-over-year and $34 million above Q1’s record, with product revenue $181.3 million and service revenue $52.7 million. Gross profit was $84.6 million versus $46.4 million a year earlier.
Backlog reached a record $2.36 billion, up 137% year-over-year, and the company cited more than $1 billion in new contracts already entered into in Q3 across launch and space systems. Net loss for Q2 narrowed to $49.3 million (‑$0.08 per share) from $66.4 million (‑$0.13 per share) in Q2 2025.
Rocket Lab closed the acquisitions of Mynaric and Motiv and announced an agreement to acquire Iridium Communications. Q2 and post‑quarter signings added more than $437 million in new launch contracts, bringing launch backlog to 90+ missions. Cash and cash equivalents rose to $2.13 billion, supported by $1.53 billion of ATM equity offering proceeds.
For Q3 2026, Rocket Lab guides revenue between $250 million and $265 million, GAAP gross margin of 29%–31%, non‑GAAP gross margin of 35%–37%, GAAP operating expenses of $143–$149 million, non‑GAAP operating expenses of $121–$127 million, and an Adjusted EBITDA loss of $17–$23 million.
Positive
- Revenue $234.1M in Q2 2026, up 62% year-over-year
- Record backlog $2.36B, a 137% increase year-over-year
- New contracts >$1B already entered into in Q3 2026
- New launch contracts >$437M in Q2 plus post-quarter, 90+ launches in backlog
- Net loss improved to $49.3M from $66.4M in Q2 2025
- Cash and cash equivalents $2.13B, aided by $1.53B ATM equity proceeds
Negative
- Q2 operating loss $57.5M, with total operating expenses at $142.1M
- Net loss $94.3M for the first six months of 2026
- Operating cash outflow $134.4M in H1 2026, higher than $77.5M in H1 2025
- Research and development expense $82.4M in Q2, up from $66.1M year-over-year
- Selling, general and administrative expense $59.7M in Q2, up from $39.9M
- Share count dilution: basic weighted-average shares rose to 629.7M from 515.1M year-over-year
News Explained
Rocket Lab’s reported share base is larger, and Q3 guidance includes approximately 41 million preferred shares, diluting existing holders absent offsets.
The Q2 results release adds an ownership consequence: as of
Because additional shares increase total share count and reduce an existing holder’s percentage ownership absent offsetting changes, these reported increases indicate dilution for existing common holders.
For Q3, the company guides to basic weighted-average common shares outstanding of
A separate execution watch is Neutron’s Stage 1 tank delivery target for
Market Reaction – RKLB
Following this news, RKLB has declined 2.05%, reflecting a moderate negative market reaction. Our momentum scanner has triggered 24 alerts so far, indicating elevated trading interest and price volatility. The stock is currently trading at $78.40. Trading volume is above average at 1.6x the average, suggesting increased trading activity.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
Key Figures
Previous Earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jul 09 | Q2 earnings release | Neutral | -1.8% | Iridium scheduled second-quarter results while pending Rocket Lab acquisition |
| May 07 | Q1 earnings results | Positive | +34.2% | Record revenue, backlog, liquidity, and raised second-quarter guidance |
| Feb 26 | Q4 earnings results | Positive | -4.9% | Record quarterly and annual revenue with increased backlog |
| Nov 10 | Q3 earnings results | Positive | -1.3% | Record revenue and gross margin with expanded launch activity |
| Aug 07 | Q2 earnings results | Positive | +1.1% | Record revenue and gross-margin expansion alongside contract and product updates |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Tag-specific earnings reactions were positive in two of five events and negative in three, indicating inconsistent responses to earnings announcements.
Key Terms
gaap financial
non-gaap financial
adjusted ebitda financial
atm equity offerings financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
LONG BEACH, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB), a global leader in launch services and space systems, today shared the financial results for fiscal second quarter ended June 30, 2026.
Rocket Lab founder and CEO, Sir Peter Beck, says: “Q2 was another fantastic quarter for Rocket Lab, highlighted by record results and massive momentum that has continued well after the close. We achieved a record
“Alongside this execution, we closed the acquisitions of Mynaric and Motiv and announced our historic deal to acquire Iridium Communications Inc. Together, these moves position Rocket Lab to accelerate our future into space applications by becoming a self-launching, tier-1 space power that will deliver critical communications capability to millions of users worldwide.”
Highlights for the Second Quarter 2026, plus business updates since June 30, 2026.
- Record quarterly revenue of
$234 million , a62% increase YoY. - Record backlog of
$2.36 billion , a137% increase YoY. - Announced a landmark agreement to acquire Iridium to create a fully vertically-integrated space powerhouse that designs, builds, launches, and operates its own constellations, delivering critical communications capability to millions of users worldwide.
- Secured more than
$437 million [1] in new launch contracts across its Electron, HASTE, and Neutron launch vehicles during Q2 2026 plus post-quarter signings, expanding Rocket Lab’s total launch backlog to its highest in history with 90+ launches. - Introduced the Company’s GHOST globally-deployable launch system to support suborbital and orbital launches from anywhere in the world. GHOST’s first location – named Rocket Lab Launch Complex 4 - will be at the Pacific Spaceport Complex at Kodiak, Alaska, with two pads to be established for high-frequency launch campaigns. The system is set to make its operational debut with a suborbital launch from Alaska in 2027.
- Achieved critical milestones across Neutron’s assembly, integration, and testing of first-flight hardware as Rocket Lab progresses toward the inaugural launch of its medium-lift reusable rocket. Production of the Stage 1 tank is currently aligned with the target delivery of Neutron to the launch pad in Q4 2026.
- Awarded a
$397 2 million contract to deliver multiple Flatellite spacecraft to launch on Neutron for the U.S. Space Force’s Space-Based Airborne Moving Target Indicator (SB-AMTI) program: a critically-important mission for national security to detect, track, and monitor airborne threats from space. Rocket Lab is one of only two vendors delivering launch-plus-spacecraft for SB-AMTI: a compelling recognition of the value of Rocket Lab’s strategic vertical integration. - Awarded more than
$160 million across two contracts to build three geostationary satellites. The deals include a prime contract with the Space Force’s Space Systems Command to build and operate two satellites for space domain awareness, representing Rocket Lab’s first foray into geostationary satellite production and operation for the U.S. Government. - Formally established Rocket Lab Germany GmbH to support potential future scaling of Rocket Lab satellite and component manufacturing in Germany and provide commercial and sovereign space capabilities to European customers.
Third Quarter 2026 Guidance
For the third quarter of 2026, Rocket Lab expects:
- Revenue between
$250 million and$265 million . - GAAP Gross Margins between
29% and31% . - Non-GAAP Gross Margins between
35% and37% . - GAAP Operating Expenses between
$143 million and$149 million . - Non-GAAP Operating Expenses between
$121 million and$127 million . - Interest Income, net
$21 million . - Adjusted EBITDA loss of between
$17 million and$23 million . - Basic Weighted Average Common Shares Outstanding of 641 million, including approximately 41 million of Series A Convertible Participating Preferred Shares.
See “Use of Non-GAAP Financial Measures” below for an explanation of our use of Non-GAAP financial measures, and the reconciliation of historical Non-GAAP measures to the comparable GAAP measures in the tables attached to this press release. We have not provided a reconciliation for the forward-looking Non-GAAP Gross Margin, Non-GAAP Operating Expenses or Adjusted EBITDA expectations for Q3 2026 described above because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate these non-GAAP financial measures, particularly related to stock-based compensation and its related tax effects. Stock-based compensation is currently expected to range from
________________________________
1 Includes options across various contracts.
2 Includes options across various contracts.
Conference Call Information
Rocket Lab will host a conference call for investors at 2 p.m. PT (5 p.m. ET) today to discuss these business highlights and financial results for our second quarter, other updates, and to provide our outlook for the third quarter 2026.
The live webcast and a replay of the webcast will be available on Rocket Lab’s Investor Relations website: https://investors.rocketlabcorp.com/
Rocket Lab Investor Relations Contact
Patrick Vorenkamp
investors@rocketlabusa.com
Rocket Lab Media Contact
Murielle Baker
media@rocketlabusa.com
About Rocket Lab
Rocket Lab (Nasdaq: RKLB) is an end-to-end space company delivering rockets, satellites, and spacecraft components for commercial, government, and defense missions. Driven by its industry-leading small-lift rockets Electron and HASTE and its upcoming reusable Neutron medium-lift rocket, Rocket Lab delivers reliable and responsive launch for the world’s most important missions from constellation deployment to missile defense. Rocket Lab’s satellites and components have powered more than 1,700 missions in Earth orbit, as well as deep-space exploration of the Moon, Mars, and beyond. Learn more at www.rocketlabcorp.com.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our expectations of financial results for the third quarter of 2026, launch and space systems operations, launch schedule and window, safe and repeatable access to space, Neutron development and anticipated timeline to launch, operational expansion, business strategy, our backlog, revenue momentum, and contract activity; and the anticipated benefits or impacts of our acquisitions of Mynaric, Motiv, and the announced transaction involving Iridium Communications are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “potential,” “continue,” “anticipate,” “intend,” “expect,” “strategy,” “future,” “could,” “would,” “project,” “plan,” “target,” and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to the factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the “SEC”), accessible on the SEC’s website at www.sec.gov and the Investor Relations section of our website at investors.rocketlabcorp.com, which could cause our actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.
Use of Non-GAAP Financial Measures
We supplement the reporting of our financial information determined under Generally Accepted Accounting Principles in the United States of America (“GAAP”) with certain non-GAAP financial information. The non-GAAP financial information presented excludes certain significant items that may not be indicative of, or are unrelated to, results from our ongoing business operations. We believe that these non-GAAP measures provide investors with additional insight into the company's ongoing business performance. These non-GAAP measures should not be considered in isolation or as a substitute for the related GAAP measures, and other companies may define such measures differently. We encourage investors to review our financial statements and publicly filed reports in their entirety and not to rely on any single financial measure. Reconciliation of the non-GAAP financial information to the corresponding GAAP measures for the historical periods disclosed are included at the end of the tables in this press release. We have not provided a reconciliation for forward-looking non-GAAP financial measures because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate these non-GAAP financial measures, particularly related to stock-based compensation and its related tax effects. The following definitions are provided:
Adjusted EBITDA
EBITDA is defined as earnings before interest, taxes, depreciation and amortization. Adjusted EBITDA further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from net income or loss to determine Adjusted EBITDA. Management believes this measure provides investors meaningful insight into results from ongoing operations.
Other Non-GAAP Financial Measures
Non-GAAP gross profit, gross margin, research and development, net, selling, general and administrative, operating expenses, operating loss and total other income (expense), net, further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from the applicable GAAP financial measure. Management believes these non-GAAP measures provide investors meaningful insight into results from ongoing operations.
| ROCKET LAB CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2026 AND 2025 (unaudited; in thousands, except share and per share data) | |||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Revenues: | |||||||||||||||
| Product revenues | $ | 181,347 | $ | 92,725 | $ | 308,835 | $ | 173,529 | |||||||
| Service revenues | 52,719 | 51,773 | 125,579 | 93,538 | |||||||||||
| Total revenues | 234,066 | 144,498 | 434,414 | 267,067 | |||||||||||
| Cost of revenues: | |||||||||||||||
| Cost of product revenues | 117,439 | 61,692 | 198,523 | 115,561 | |||||||||||
| Cost of service revenues | 32,051 | 36,418 | 74,822 | 69,871 | |||||||||||
| Total cost of revenues | 149,490 | 98,110 | 273,345 | 185,432 | |||||||||||
| Gross profit | 84,576 | 46,388 | 161,069 | 81,635 | |||||||||||
| Operating expenses: | |||||||||||||||
| Research and development, net | 82,429 | 66,134 | 162,942 | 121,243 | |||||||||||
| Selling, general and administrative | 59,661 | 39,893 | 111,610 | 79,219 | |||||||||||
| Total operating expenses | 142,090 | 106,027 | 274,552 | 200,462 | |||||||||||
| Operating loss | (57,514 | ) | (59,639 | ) | (113,483 | ) | (118,827 | ) | |||||||
| Other income (expense): | |||||||||||||||
| Interest expense | (581 | ) | (7,390 | ) | (1,855 | ) | (14,185 | ) | |||||||
| Interest income | 16,486 | 5,019 | 26,635 | 9,228 | |||||||||||
| Loss on foreign exchange | (1,954 | ) | (489 | ) | (1,798 | ) | (623 | ) | |||||||
| Other expense, net | (368 | ) | (977 | ) | (244 | ) | (498 | ) | |||||||
| Total other income (expense), net | 13,583 | (3,837 | ) | 22,738 | (6,078 | ) | |||||||||
| Loss before income taxes | (43,931 | ) | (63,476 | ) | (90,745 | ) | (124,905 | ) | |||||||
| Provision for income taxes | (5,327 | ) | (2,938 | ) | (3,535 | ) | (2,125 | ) | |||||||
| Net loss | $ | (49,258 | ) | $ | (66,414 | ) | $ | (94,280 | ) | $ | (127,030 | ) | |||
| Net loss per share attributable to Rocket Lab Corporation: | |||||||||||||||
| Basic and diluted | $ | (0.08 | ) | $ | (0.13 | ) | $ | (0.15 | ) | $ | (0.25 | ) | |||
| Weighted-average common shares outstanding: | |||||||||||||||
| Basic and diluted | 629,681,803 | 515,086,631 | 617,625,210 | 510,376,584 | |||||||||||
| ROCKET LAB CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS AS OF JUNE 30, 2026 AND DECEMBER 31, 2025 (unaudited; in thousands, except share and per share values) | |||||||
| June 30, 2026 | December 31, 2025 | ||||||
| Assets | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 2,129,485 | $ | 828,660 | |||
| Marketable securities, current | 172,700 | 187,917 | |||||
| Accounts receivable, net | 112,889 | 39,001 | |||||
| Contract assets | 94,245 | 61,606 | |||||
| Inventories | 266,931 | 158,407 | |||||
| Prepaids and other current assets | 119,509 | 89,953 | |||||
| Total current assets | 2,895,759 | 1,365,544 | |||||
| Non-current assets: | |||||||
| Property, plant and equipment, net | 393,946 | 319,473 | |||||
| Intangible assets, net | 320,415 | 224,746 | |||||
| Goodwill | 299,072 | 205,750 | |||||
| Right-of-use assets - operating leases | 113,690 | 90,371 | |||||
| Right-of-use assets - finance leases | 12,349 | 13,895 | |||||
| Marketable securities, non-current | 85,405 | 82,247 | |||||
| Restricted cash | 8,413 | 4,885 | |||||
| Deferred income tax assets, net | 1,057 | 1,895 | |||||
| Other non-current assets | 57,268 | 15,672 | |||||
| Total assets | $ | 4,187,374 | $ | 2,324,478 | |||
| Liabilities and Stockholders’ Equity | |||||||
| Current liabilities: | |||||||
| Trade payables | $ | 74,512 | $ | 72,699 | |||
| Accrued expenses | 44,206 | 19,299 | |||||
| Employee benefits payable | 29,118 | 25,803 | |||||
| Contract liabilities | 351,193 | 195,438 | |||||
| Other current liabilities | 29,167 | 21,237 | |||||
| Total current liabilities | 528,196 | 334,476 | |||||
| Non-current liabilities: | |||||||
| Convertible senior notes, net | 13,129 | 152,395 | |||||
| Long-term borrowings, net | 1,716 | 1,716 | |||||
| Non-current operating lease liabilities | 104,378 | 85,191 | |||||
| Non-current finance lease liabilities | 14,468 | 14,653 | |||||
| Deferred income tax liabilities | 10,146 | 1,241 | |||||
| Other non-current liabilities | 23,188 | 12,952 | |||||
| Total liabilities | 695,221 | 602,624 | |||||
| COMMITMENTS AND CONTINGENCIES | |||||||
| Stockholders’ equity: | |||||||
| Preferred stock, | 4 | 5 | |||||
| Common stock, | 60 | 54 | |||||
| Treasury stock, at cost; shares: 40,951,250 and 45,951,250 at June 30, 2026 and December 31, 2025, respectively | — | — | |||||
| Additional paid-in capital | 4,606,854 | 2,735,669 | |||||
| Accumulated deficit | (1,106,190 | ) | (1,011,910 | ) | |||
| Accumulated other comprehensive loss | (8,575 | ) | (1,964 | ) | |||
| Total stockholders’ equity | 3,492,153 | 1,721,854 | |||||
| Total liabilities and stockholders’ equity | $ | 4,187,374 | $ | 2,324,478 | |||
| ROCKET LAB CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE SIX MONTHS ENDED JUNE 30, 2026 AND 2025 (unaudited; in thousands) | |||||||
| For the Six Months Ended June 30, | |||||||
| 2026 | 2025 | ||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||
| Net loss | $ | (94,280 | ) | $ | (127,030 | ) | |
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||||
| Depreciation and amortization | 35,933 | 17,465 | |||||
| Stock-based compensation expense | 47,677 | 37,167 | |||||
| (Gain) loss on disposal of assets | (403 | ) | 1,503 | ||||
| Lower of cost or market inventory valuation adjustment | 5,802 | — | |||||
| Amortization of debt issuance costs and discount | 179 | 1,691 | |||||
| Noncash lease expense | 5,629 | 3,565 | |||||
| Change in the fair value of contingent consideration | 386 | — | |||||
| Accretion of marketable securities purchased at a discount | (873 | ) | (1,099 | ) | |||
| Deferred income taxes | 1,409 | 1,454 | |||||
| Changes in operating assets and liabilities: | |||||||
| Accounts receivable, net | (63,023 | ) | (25,317 | ) | |||
| Contract assets | (30,057 | ) | 11,193 | ||||
| Inventories | (73,331 | ) | (11,513 | ) | |||
| Prepaids and other current assets | (6,881 | ) | (18,037 | ) | |||
| Other non-current assets | (40,337 | ) | 11,879 | ||||
| Trade payables | (3,124 | ) | 11,149 | ||||
| Accrued expenses | 8,963 | 4,024 | |||||
| Employee benefits payables | (3,375 | ) | 3,289 | ||||
| Contract liabilities | 78,835 | 7,217 | |||||
| Other current liabilities | 2,788 | 98 | |||||
| Non-current lease liabilities | (6,467 | ) | (6,547 | ) | |||
| Other non-current liabilities | 143 | 382 | |||||
| Net cash used in operating activities | (134,407 | ) | (77,467 | ) | |||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||
| Purchases of property, equipment and software | (53,112 | ) | (60,719 | ) | |||
| Proceeds on disposal of assets | 715 | 144 | |||||
| Cash paid for business combinations, net of acquired cash | (44,271 | ) | — | ||||
| Purchases of marketable securities | (149,519 | ) | (128,325 | ) | |||
| Maturities of marketable securities | 161,579 | 149,495 | |||||
| Sale of marketable securities | — | 3,383 | |||||
| Net cash used in investing activities | (84,608 | ) | (36,022 | ) | |||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||
| Proceeds from ATM Equity Offerings | 1,529,639 | 396,647 | |||||
| Issuance costs related to ATM Equity Offerings | (16,722 | ) | (9,496 | ) | |||
| Proceeds from the exercise of stock options | 1,278 | 379 | |||||
| Proceeds from Employee Stock Purchase Plan | 8,792 | 4,836 | |||||
| Proceeds from sale of employees restricted stock units to cover taxes | 151,719 | 40,715 | |||||
| Minimum tax withholding paid on behalf of employees for restricted stock units | (151,154 | ) | (40,421 | ) | |||
| Proceeds from secured term loans | — | 25,000 | |||||
| Repayments on secured term loan | — | (11,208 | ) | ||||
| Payment of debt issuance costs | — | (278 | ) | ||||
| Finance lease principal payments | (149 | ) | (126 | ) | |||
| Net cash provided by financing activities | 1,523,403 | 406,048 | |||||
| Effect of exchange rate changes on cash and cash equivalents | (35 | ) | 1,127 | ||||
| Net increase in cash and cash equivalents and restricted cash | 1,304,353 | 293,686 | |||||
| Cash and cash equivalents, and restricted cash, beginning of period | 833,545 | 275,302 | |||||
| Cash and cash equivalents, and restricted cash, end of period | $ | 2,137,898 | $ | 568,988 | |||
ROCKET LAB CORPORATION AND SUBSIDIARIES
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2026 AND 2025
(unaudited; in thousands)
The tables provided below reconcile the non-GAAP financial measures Adjusted EBITDA, Non-GAAP gross profit, Non-GAAP research and development, net, Non-GAAP selling, general and administrative, Non-GAAP operating expenses, Non-GAAP operating loss and Non-GAAP total other income (expense), net with the most directly comparable GAAP financial measures. See above for additional information on the use of these non-GAAP financial measures.
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| NET LOSS | $ | (49,258 | ) | $ | (66,414 | ) | $ | (94,280 | ) | $ | (127,030 | ) | |||
| Depreciation | 10,172 | 5,882 | 17,686 | 11,571 | |||||||||||
| Amortization | 10,771 | 2,876 | 18,247 | 5,894 | |||||||||||
| Stock-based compensation expense | 19,561 | 17,933 | 47,677 | 37,167 | |||||||||||
| Transaction costs | 8,576 | 5,008 | 10,244 | 6,386 | |||||||||||
| Interest expense | 581 | 7,390 | 1,855 | 14,185 | |||||||||||
| Interest income | (16,486 | ) | (5,019 | ) | (26,635 | ) | (9,228 | ) | |||||||
| Change in fair value of contingent consideration | 199 | — | 386 | — | |||||||||||
| Amortization of inventory step-up | 183 | — | 183 | — | |||||||||||
| Provision for income taxes | 5,327 | 2,938 | 3,535 | 2,125 | |||||||||||
| Loss on foreign exchange | 1,954 | 489 | 1,798 | 623 | |||||||||||
| Accretion of marketable securities and cash equivalents purchased at a discount | (419 | ) | (672 | ) | (877 | ) | (1,257 | ) | |||||||
| Loss (gain) on disposal of assets | 6 | 1,490 | (403 | ) | 1,503 | ||||||||||
| Employee retention credit | — | 515 | — | 515 | |||||||||||
| ADJUSTED EBITDA | $ | (8,833 | ) | $ | (27,584 | ) | $ | (20,584 | ) | $ | (57,546 | ) | |||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| GAAP Gross profit | $ | 84,576 | $ | 46,388 | $ | 161,069 | $ | 81,635 | |||||||
| Stock-based compensation | 5,090 | 4,892 | 8,596 | 8,812 | |||||||||||
| Amortization of purchased intangibles and favorable lease | 7,184 | 1,823 | 13,278 | 3,646 | |||||||||||
| Amortization of inventory step-up | 183 | — | 183 | — | |||||||||||
| Employee retention credit | — | 278 | — | 278 | |||||||||||
| Non-GAAP Gross profit | $ | 97,033 | $ | 53,381 | $ | 183,126 | $ | 94,371 | |||||||
| Non-GAAP Gross margin | 41.5 | % | 36.9 | % | 42.2 | % | 35.3 | % | |||||||
| GAAP Research and development, net | $ | 82,429 | $ | 66,134 | $ | 162,942 | $ | 121,243 | |||||||
| Stock-based compensation | (6,934 | ) | (5,573 | ) | (12,780 | ) | (10,467 | ) | |||||||
| Amortization of purchased intangibles and favorable lease | — | (164 | ) | — | (329 | ) | |||||||||
| Employee retention credit | — | (88 | ) | — | (88 | ) | |||||||||
| Non-GAAP Research and development, net | $ | 75,495 | $ | 60,309 | $ | 150,162 | $ | 110,359 | |||||||
| GAAP Selling, general and administrative | $ | 59,661 | $ | 39,893 | $ | 111,610 | $ | 79,219 | |||||||
| Stock-based compensation | (7,537 | ) | (7,468 | ) | (26,301 | ) | (17,888 | ) | |||||||
| Amortization of purchased intangibles and favorable lease | (3,302 | ) | (628 | ) | (4,407 | ) | (1,404 | ) | |||||||
| Transaction costs | (8,576 | ) | (5,008 | ) | (10,244 | ) | (6,386 | ) | |||||||
| Employee retention credit | — | (149 | ) | — | (149 | ) | |||||||||
| Non-GAAP Selling, general and administrative | $ | 40,246 | $ | 26,640 | $ | 70,658 | $ | 53,392 | |||||||
| GAAP Operating expenses | $ | 142,090 | $ | 106,027 | $ | 274,552 | $ | 200,462 | |||||||
| Stock-based compensation | (14,471 | ) | (13,041 | ) | (39,081 | ) | (28,355 | ) | |||||||
| Amortization of purchased intangibles and favorable lease | (3,302 | ) | (792 | ) | (4,407 | ) | (1,733 | ) | |||||||
| Transaction costs | (8,576 | ) | (5,008 | ) | (10,244 | ) | (6,386 | ) | |||||||
| Employee retention credit | — | (237 | ) | — | (237 | ) | |||||||||
| Non-GAAP Operating expenses | $ | 115,741 | $ | 86,949 | $ | 220,820 | $ | 163,751 | |||||||
| GAAP Operating loss | $ | (57,514 | ) | $ | (59,639 | ) | $ | (113,483 | ) | $ | (118,827 | ) | |||
| Total non-GAAP adjustments | 38,806 | 26,071 | 75,789 | 49,447 | |||||||||||
| Non-GAAP Operating loss | $ | (18,708 | ) | $ | (33,568 | ) | $ | (37,694 | ) | $ | (69,380 | ) | |||
| GAAP Total other income (expense), net | $ | 13,583 | $ | (3,837 | ) | $ | 22,738 | $ | (6,078 | ) | |||||
| Loss on foreign exchange | 1,954 | 489 | 1,798 | 623 | |||||||||||
| Loss (gain) on disposal of assets | 6 | 1,490 | (403 | ) | 1,503 | ||||||||||
| Change in fair value of contingent consideration | 199 | — | 386 | — | |||||||||||
| Non-GAAP Total other income (expense), net | $ | 15,742 | $ | (1,858 | ) | $ | 24,519 | $ | (3,952 | ) | |||||
